Why is Ipca Labs falling/rising?

As of 14-Nov, Ipca Laboratories Ltd is experiencing a significant rise in its stock price, currently at 1,494.50, reflecting an increase of 191.8 or 14.72%. Today's price performance indicates that the stock has outperformed its sector by 14.35%, reaching an intraday high of Rs 1549.85, which is an 18.97% increase. The stock has shown high volatility today with an intraday volatility of 7.66%, and it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has seen a rise in delivery volume, increasing by 33.67% against the 5-day average, suggesting growing investor interest. Despite a year-to-date decline of 11.65%, the stock has demonstrated strong performance over the past three years with a return of 71.69%.
In the broader market context, the stock's short-term return of 13.07% over the past week significantly outpaces the Sensex's return of 1.62%, indicating a strong relative performance. The company's fundamentals are also robust, with a low debt-to-equity ratio of 0.03, a substantial operating profit growth of 27.55%, and consistent positive results over the last six quarters. With a return on equity of 13.2 and a price-to-book value of 5.1, the stock is considered fairly valued compared to its peers. High institutional holdings at 47.2% further support the stock's stability, as these investors typically possess better analytical capabilities. Overall, these factors contribute to the stock's upward movement, reflecting positive investor sentiment and strong operational performance.